# A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus

> **NCT05302050** · NA · UNKNOWN · sponsor: **Better Therapeutics** · enrollment: 500 (actual)

## Conditions studied

- Diabetes Type 2

## Interventions

- **DEVICE:** BT-001
- **DEVICE:** Control Mobile Application

## Key facts

- **NCT ID:** NCT05302050
- **Lead sponsor:** Better Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-07
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05302050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05302050, "A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05302050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*